DUBLIN – (BUSINESS WIRE) – January 5, 2022–

The report “Asia Digital Advertising in Pharma Market Outlook 2030” has been added to the offering of ResearchAndMarkets.com.

The digital advertising in Asia in the pharmaceutical market is expected to grow at a CAGR of 13.8% during the forecast period, i.e. 2021-2030.

Digital advertising in Asia in the pharmaceutical market is expected to generate approximately $ 22,260 million in revenue by the end of 2030, up from nearly $ 3,630 million in 2015.

As the healthcare industry grows online at scale, digital advertising in the pharmaceutical industry is therefore one of the easiest ways to meet prospects and advertise pharmaceutical products and services.

Factors such as the growing awareness of digital advertising among pharmaceutical companies, supported by the many advantages associated with the advertising method, such as cost efficiency and scalability, as well as the increase of the pharmaceutical industry in Asia are expected to drive market growth in the coming years.

The Asian pharmaceutical market digital advertising market is segmented into many segments including segmentation by ad format, product type, category, platform and country. By platform, the market is segmented into mobile, desktop, and other platforms. Of these, in 2015, the mobile segment generated revenue of nearly $ 2,600 million. The segment is also expected to exceed $ 16,590 million by the end of 2030.

By Country, Asia Digital Advertising in Pharmaceutical Market is Segmented into Singapore, Indonesia, Thailand, Malaysia, Vietnam, Philippines, Hong Kong, Taiwan, Japan, South Korea, Rest Southeast Asia and the rest of Asia.

Of these, by the end of 2030, the Japanese market is expected to hold the second largest revenue of around $ 4,940 million. In 2015, the region’s market generated sales of approximately $ 880 million.

Some of the main industry leaders are

  • BBDO
  • AMICULUM Limited
  • WebHopers Infotech PVT. LTD.
  • The Ogilvy group
  • WebFX
  • Amura Commercialization Technologies
  • Medibrandox

Main topics covered:

1. Market definition and research methodology

2. Analyst review

3. Executive summary

4. Market dynamics

4.1. Conductors

4.2. Challenges

4.3. Tendencies

4.4. Opportunities

5. Industry analysis

5.1. Regulatory and standard landscape

5.2. Industry risk analysis

5.3. Consumer behavior analysis

6. Impact of COVID-19 on the Asian digital advertising market in the pharmaceutical market

7. Analysis of expenses on the medical pharmaceutical sales representative

8. Analysis of advertising expenditure on pharmaceutical products

9. Analysis of spending on product sales incentives and programs

10. Analysis on pharmaceutical companies

11. Competitive positioning

12. Comparative analysis of characteristics

13. Competitive landscape

14. Digital advertising in Asia in the pharmaceutical market

14.1. Market Overview – Market Size (2015-2030)

14.2. Market segmentation by:

14.2.1. Announcement format

14.2.1.1. Social Media Ads, 2015-2030 (USD Million)

14.2.1.2. Native Announcements, 2015-2030 (USD Million)

14.2.1.3. Search Engine Ads, 2015-2030 (USD Million)

14.2.1.4. Display ads, 2015-2030 (in millions of USD)

14.2.1.5. Video Advertising, 2015-2030 (USD Million)

14.2.1.6. Mobile Advertising, 2015-2030 (USD Million)

14.2.1.7. Banner Ads, 2015-2030 (USD Million)

14.2.1.8. Other announcements, 2015-2030 (in millions of USD)

14.2.2. type of product

14.2.2.1. Patent Medicine, 2015-2030 (USD Million)

14.2.2.2. Generic Medicine, 2015-2030 (USD Million)

14.2.3. Category

14.2.3.1. Prescription Drugs, 2015-2030 (USD Million)

14.2.3.2. Over-the-Counter Drugs, 2015-2030 (USD Million)

14.2.4. Platform

14.2.4.1. Mobile, 2015-2030 (USD million)

14.2.4.2. Desktop Computer, 2015-2030 (USD Million)

14.2.4.3. Other platforms, 2015-2030 (in millions of USD)

14.2.5. Country

14.2.5.1. Singapore

14.2.5.2. Indonesia

14.2.5.3. Thailand

14.2.5.4. Malaysia

14.2.5.5. Vietnam

14.2.5.6. Philippines

14.2.5.7. Hong Kong

14.2.5.8. Taiwan

14.2.5.9. Japan

14.2.5.10. South Korea

14.2.5.11. Rest of Southeast Asia

14.2.5.12. Rest of asia

For more information on this report, visit https://www.researchandmarkets.com/r/oohghl

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220105005746/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Director

[email protected]

For EST office hours, call 1-917-300-0470

For USA / CAN call toll free 1-800-526-8630

For GMT office hours, call + 353-1-416-8900

KEYWORD: ASIA PACIFIC

INDUSTRY KEYWORD: ADVERTISING COMMUNICATION HEALTH TECHNOLOGY INTERNET PHARMACEUTICAL

SOURCE: Research and markets

Copyright Business Wire 2022.

PUB: 05/01/2022 10:20 a.m. / DISC: 05/01/2022 10:22 a.m.

http://www.businesswire.com/news/home/20220105005746/en

Recent stories you might have missed


Source link